The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.

Neoptolemos JP, Springfeld C, Öhlund D, Büchler MW, Michalski CW

DOI: 10.1016/s1470-2045(25)00601-1
Published: 2026 Jan
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-25-00601-1,
  title = {The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.},
  author = {Neoptolemos JP and Springfeld C and Öhlund D and Büchler MW and Michalski CW},
  year = {2026},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(25)00601-1},
  url = {https://doi.org/10.1016/s1470-2045(25)00601-1}
}

RIS

TY  - JOUR
TI  - The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.
AU  - Neoptolemos JP
AU  - Springfeld C
AU  - Öhlund D
AU  - Büchler MW
AU  - Michalski CW
PY  - 2026
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(25)00601-1
UR  - https://doi.org/10.1016/s1470-2045(25)00601-1
ER  -

APA

JP, N., C, S., D, Ö., MW, B., & CW, M. (2026). The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(25)00601-1

Source records

pubmed · retrieved 2026-09-27T08:14:40.425Z